(NASDAQ:HIIQ)'s short data and trying to figure out market sentiment on which way the market thinks the stock is moving. They generally move extremely slowly and they only produce big price swings when the company produces good or bad trading results, which may only happen a couple of times a year at best.
Several other equities analysts have also recently issued reports on the company. Awesome Oscillator buy signals are created when the indicator crosses from below 0 to above 0, and sell signals when reversed. The total amount of shares outstanding is 232.19M, giving the company a market capitalization of about 1.60B. ValuEngine raised Health Insurance Innovations from a hold rating to a buy rating in a research report on Friday, September 1st.
Going out even further, the 200-Day Simple Moving Average is recorded 45.52% away from the current share price. Finally, The Manufacturers Life Insurance Company increased its stake in Health Insurance Innovations by 7,616.4% in the 2nd quarter. In the a year ago there have been a total of 114 insider trades, including 16 open market buys and 98 sells. One equities research analyst has rated the stock with a hold rating and eight have issued a buy rating to the company. The stock presently has a consensus rating of "Buy" and an average target price of $31.33. The shares price has positioned -41.37% down over the past quarter while it has directed -11.60% toward a falling position throughout past six months.
Health Insurance Innovations (NASDAQ HIIQ) traded down 21.51% on Thursday, reaching $14.60. In looking the SMA 50 we see that the stock has seen a -51.00% while it has a distance of -34.19% from the 200 days simple moving average. The CEO of HealthPocket, Inc.* now owns $2,374,547 of the stock per the Form 4 SEC filing.
Analyst use beta to measure a stock's volatility relative to the overall market. The current consensus recommendation provided by covering analysts is 1.90. The return on assets stands at 8.8%, Return on Equity now is 19.8% and the Return on Investment value is 47.4%. The firm had revenue of $61.80 million for the quarter, compared to analysts' expectations of $53.69 million. The business's quarterly revenue was up 38.9% compared to the same quarter previous year.
There has been some selling insider activity on Health Insurance Innovations, I (NASDAQ:HIIQ) recently. If you are accessing this report on another publication, it was illegally copied and reposted in violation of USA & worldwide copyright & trademark laws.
Akorn, Inc. (AKRX) stock moved with shift of 0.09% in the past week. With short interest at 1,668,281 and short average daily volume at 503,840, the short-interest ratio is 3.0 and the percentage of shorted shares is 0.14% as of August 31. Following the transaction, the chief executive officer now owns 104,001 shares of the company's stock, valued at approximately $2,774,746.68. Also, CFO Michael D. Hershberger sold 5,000 shares of Health Insurance Innovations stock in a transaction dated Monday, July 3rd.
A cheap stock is not necessarily a value stock. They should not be utilized to make stock portfolio or financial decisions as they are based only on limited and open source information. The disclosure for this sale can be found here. The company's quarterly EPS surprised Wall Street by as much as -27% to the downside in its last earnings announcement, so investors should note this tendency when assessing consensus estimates. Among this group of ratios is the turnover to capital employed or return on investment (ROI) ratio.
Health Insurance Innovations Inc (HIIQ) are being closely watched by investors as the firm's Mesa Adaptive Moving Average (MAMA) has dipped below the Fractional Adaptive Moving Average (FAMA), indicating that a potential bearish move might be forthcoming. The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of stock price movements. Finally, Cortina Asset Management LLC purchased a new stake in Health Insurance Innovations in the 1st quarter worth $5,192,000. Institutional investors and hedge funds own 66.21% of the company's stock.